Immunology and Microbiology
Allele
100%
Epitope
70%
Transplant Procedure
48%
Haplotype
31%
T Cell
31%
Human Leukocyte Antigen
25%
CD177
23%
Cytotoxic T-Cell
23%
Cytotoxic T Cell
22%
Allotransplantation
22%
Neutrophil
22%
Polymerase Chain Reaction
21%
Cyclophosphamide
21%
Monospecific Antibody
18%
Next Generation Sequencing
18%
Melanoma Antigen
17%
Graft-Versus-Host Disease
17%
Vaccination Policy
16%
Immune Response
16%
Immune Complex
14%
Peripheral Blood Stem Cell Transplantation
14%
Cytomegalovirus
14%
HLA DRB1 Antigen
13%
interferon
12%
HLA A24 Antigen
12%
CD8
11%
Immunotherapy
11%
HLA Typing
11%
Real-Time Polymerase Chain Reaction
11%
Acute Graft Versus Host Disease
10%
Genotype
10%
Chronic Graft Versus Host Disease
10%
Glycoprotein
9%
Vaccine Efficacy
9%
Cytokine Release Syndrome
9%
Peripheral Blood Mononuclear Cell
9%
Dendritic Cell
9%
Drug Megadose
9%
Neutrophil Granulocyte
8%
Surface Property
8%
Antigen Expression
8%
Oligonucleotide Probe
8%
Solid
8%
Recurrence Free Survival
8%
Tumor Cell
8%
Single Nucleotide Polymorphism
8%
Fibroblast Growth Factor 5
8%
Tumor Antigen
8%
Progression Free Survival
7%
Allogeneic Bone Marrow Transplantation
7%
Keyphrases
CD177
30%
Transplantation
23%
Graft-versus-host Disease (GvHD)
22%
Neutrophils
21%
HLA-A
21%
Post-transplantation Cyclophosphamide (PTCy)
21%
Confidence Interval
18%
Epitope
17%
Polymorphism
16%
HLA Matching
16%
Human Neutrophil Antigens
15%
DPB1
15%
Haploidentical Transplantation
15%
Kidney Transplant Recipients
14%
Next-generation Sequencing
14%
Metastatic Melanoma
14%
DQA1
14%
DNA Reference Materials
14%
HLA-DQB1
12%
DRB1
12%
Gp100
11%
Melanoma
11%
Genomic DNA (gDNA)
11%
Sequence-specific Oligonucleotide
10%
HLA Haplotypes
10%
Human Leukocyte Antigen
10%
Oligonucleotide Probes
10%
Nonmyeloablative
10%
Melanoma Antigens
9%
Quantitative PCR
9%
Glycoprotein
9%
Sequence-based Typing
9%
HLA-haploidentical
9%
Systemic Immune Response
8%
PRV-1
8%
Pseudogene
8%
Polymerase Chain Reaction Amplification
8%
DPA1
8%
Human Leukocyte antigen-A
8%
DRB3
8%
Single nucleotide Polymorphism
8%
Donor-specific Antibodies
8%
High Dose
8%
Mismatched Related Donor
8%
Allograft
7%
Progression-free Survival
7%
Haploidentical Peripheral Blood Stem Cell Transplantation
7%
Allogeneic Bone Marrow Transplantation
7%
Polycythemia Vera
7%
HLA Class I Molecules
7%